Practice Patterns About Management of Allergic Rhinitis: Indian HCP KAP Experience in 2024 and Preference of Fexofenadine and Montelukast Dr. Kamal Kant Kohli29 Oct 2024 10:00 AM ISTAllergic Rhinitis (AR) is the most common immune-mediated inflammatory condition affecting the nasal mucosa (1) triggered by the production of IgE...
Study Reveals Link Between Phthalate Exposure and Increased Risk of Allergic Rhinitis in Children Medha Baranwal6 Sept 2024 7:45 PM ISTKorea: A recent systematic review and meta-analysis have highlighted a concerning association between phthalate exposure and an elevated risk of...
Allergen Patterns in Moderate to Severe Allergic Rhinitis: Indian Observations and Therapeutic Utility of Fexofenadine Dr. Kamal Kant Kohli21 Aug 2024 12:00 PM ISTAllergic diseases are a major public health concern globally including in India with more than 25% of the population being sensitized to varied...
Active Smoking Reduces Long-Term Benefits of subcutaneous immunotherapy in Allergic Rhinitis Patients, Study Finds Medha Baranwal16 Aug 2024 8:15 AM ISTChina: A recent study published in Otolaryngology-Head and Neck Surgery has highlighted significant insights into how smoking affects allergic...
Allergic Rhinitis and ENT Practice: Review and Evidence Emphasis on Fluticasone Furoate Dr. Kamal Kant Kohli11 July 2024 12:00 PM ISTAllergic rhinitis (AR) affects approximately 25% and 40% of children and adults globally, respectively. In 80% of the cases, the symptoms occur before...
Allergic Rhinitis and Co-morbid Asthma: All Clinician Needs to Know and Consideration of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli6 May 2024 11:30 AM ISTAllergic rhinitis (AR), a prevalent non-infectious disease condition; is an IgE-mediated response to allergens, causing symptoms like sneezing,...
Intranasal Medications Show Efficacy in Treating Allergic Rhinitis: Study Dr Riya Dave3 May 2024 8:00 AM ISTResearchers have found that most intranasal medications, including corticosteroids and antihistamines, are effective in improving nasal and ocular...
Intratonsillar Immunotherapy Safe and Effective for Allergic Rhinitis, suggests research Dr Riya Dave2 April 2024 2:15 AM ISTAllergic rhinitis (AR) is a common condition affecting millions globally, often triggered by allergens such as house dust mites (HDM)....
Allergic Rhinitis: Challenges, Treatment Choices and Clinical Spotlight on Fexofenadine Dr. Kamal Kant Kohli1 April 2024 10:30 AM ISTAllergic rhinitis (AR) is a common inflammatory disease affecting the nasal mucosa, induced by inhaled allergens. It is clinically manifested by...
Allergic Rhinitis Aggravated by Air Pollutants: Review of International Expert Consensus and Clinical Essay on Fexofenadine Dr. Kamal Kant Kohli16 March 2024 12:43 PM ISTAllergic rhinitis (AR) has become a progressively prevalent inflammatory condition affecting the nasal mucosa, often stemming from exposure to inhaled...
Allergic Rhinitis in Children: Review of Indian Guidelines and Applicability of Fexofenadine Dr. Kamal Kant Kohli28 Feb 2024 11:00 AM ISTAllergic rhinitis is a common disease that frequently occurs in children and adolescents. The disease has a significant burden that impacts sleep,...
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
